1.79

1.11% -0.01

Inmune Bio Inc (INMB)

Overview News Price History Option Chain Financials Discussions Forecast

Inmune Bio Inc stock is traded at $1.79, with a volume of 123.31K. It is down -1.11% in the last 24 hours and down -14.42% over the past month. INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Previous Close:

$1.80

Open:

$1.77

24h Volume:

123.31K

Relative Volume:

0.13

Market Cap:

$47.59M

Revenue:

$155.00K

Net Income/Loss:

$-30.01M

P/E Ratio:

-1.0719

EPS:

-1.67

Net Cash Flow:

$-11.98M

1W Performance:

-2.20%

1M Performance:

-14.42%

6M Performance:

-77.06%

1Y Performance:

-71.52%

1-Day Range:

$1.75

$1.79

1-Week Range:

$1.73

$1.9262

52-Week Range:

$1.71

$11.64

Inmune Bio Inc Stock (INMB) Company Profile

Name

Inmune Bio Inc

Sector

Healthcare (1140)

Industry

Biotechnology (633)

Phone

(858) 964-3720

Address

225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA

Employee

Twitter

@INmuneBio

Next Earnings Date

2025-08-01

Latest SEC Filings

INMB's Discussions on Twitter

Compare INMB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INMB Inmune Bio Inc	1.79	47.85M	155.00K	-30.01M	-11.98M	-1.67
VRTX Vertex Pharmaceuticals Inc	424.67	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	631.49	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	425.97	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	838.79	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	184.66	39.72B	447.02M	-1.18B	-868.57M	-6.1812

Inmune Bio Inc Stock (INMB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-01-25	Downgrade	BTIG Research	Buy → Neutral
Jul-01-25	Downgrade	Scotiabank	Sector Outperform → Sector Underperform
Jan-28-25	Initiated	Rodman & Renshaw	Buy
Oct-21-24	Initiated	Alliance Global Partners	Buy
Sep-27-24	Initiated	Raymond James	Outperform
Aug-22-24	Initiated	Scotiabank	Sector Outperform
Jun-01-23	Initiated	Robert W. Baird	Outperform
May-24-22	Downgrade	B. Riley Securities	Buy → Neutral
Jul-07-21	Reiterated	Maxim Group	Buy
Apr-21-21	Initiated	B. Riley Securities	Buy
Jan-22-21	Reiterated	Maxim Group	Buy
Sep-01-20	Initiated	BTIG Research	Buy
Jul-15-20	Reiterated	H.C. Wainwright	Buy

View All

Inmune Bio Inc Stock (INMB) Latest News

04:07 AM

Heatmap analysis for INmune Bio Inc. and competitorsWeekly Investment Summary & Daily Volume Surge Trade Alerts - newser.com

04:07 AM

03:51 AM

Sentiment analysis tools applied to INmune Bio Inc.2025 Trade Ideas & High Conviction Investment Ideas - newser.com

03:51 AM

03:36 AM

Analyzing recovery setups for INmune Bio Inc. investorsWeekly Gains Report & Risk Controlled Swing Alerts - newser.com

03:36 AM

01:42 AM

Sector ETF performance correlation with INmune Bio Inc.July 2025 Levels & Reliable Momentum Entry Alerts - newser.com

01:42 AM

01:37 AM

How INmune Bio Inc. stock benefits from global expansionQuarterly Portfolio Report & Real-Time Volume Analysis - newser.com

01:37 AM

Nov 03, 2025

Short interest data insights for INmune Bio Inc.Trade Risk Assessment & Fast Gain Stock Tips - newser.com

Nov 03, 2025

Is INmune Bio Inc. stock overvalued by current metricsIPO Watch & Safe Capital Growth Trade Ideas - newser.com

Nov 03, 2025

Is INmune Bio Inc. a candidate for recovery playTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com

Nov 03, 2025

Does INmune Bio Inc. stock trade at a discount to peersMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com

Nov 03, 2025

Statistical indicators supporting INmune Bio Inc.’s strengthEarnings Overview Report & Short-Term High Return Ideas - newser.com

Nov 03, 2025

What makes INmune Bio Inc. stock attractive to growth fundsQuarterly Profit Review & Stock Portfolio Risk Control - newser.com

Nov 03, 2025

Earnings visualization tools for INmune Bio Inc.Rate Cut & Safe Entry Point Identification - newser.com

Nov 03, 2025

Nov 02, 2025

Published on: 2025-11-02 21:20:18 - newser.com

Nov 02, 2025

Published on: 2025-11-02 20:37:16 - newser.com

Nov 02, 2025

Can volume confirm reversal in INmune Bio Inc.2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com

Nov 02, 2025

Inmune Bio Reports Q3 2025 Financial Results - MSN

Nov 02, 2025

How INmune Bio Inc. stock reacts to Fed rate cutsPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com

Nov 02, 2025

Nov 01, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 01, 2025

Will INmune Bio Inc. stock outperform tech sector in 2025Treasury Yields & Daily Chart Pattern Signal Reports - newser.com

Nov 01, 2025

Inmune Bio to Host Q3 Results Conference Call - MSN

Nov 01, 2025

Oct 31, 2025

What analysts say about INmune Bio Inc stockMarket Liquidity Analysis & High Return Trading Ideas - earlytimes.in

Oct 31, 2025

Candlestick signals on INmune Bio Inc. stock todayWeekly Trading Summary & AI Optimized Trade Strategies - newser.com

Oct 31, 2025

Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips - Investing.com Australia

Oct 31, 2025

Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips By Investing.com - Investing.com South Africa

Oct 31, 2025

Inmune Bio outlines 2026 regulatory milestones and cash runway through Q4 2026 - MSN

Oct 31, 2025

Is it time to cut losses on INmune Bio Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com

Oct 31, 2025

Oct 30, 2025

Transcript : INmune Bio, Inc., Q3 2025 Earnings Call, Oct 30, 2025 - MarketScreener

Oct 30, 2025